C12N 15/8616
Special methods for targeting systems
Official title: {Special methods for targeting systems}
C12N15/8616 (Special methods for targeting systems) appears on 21 US grants and 32 published applications in this corpus.
Search patents in C12N- Granted patents
- 21
- Published applications
- 32
- Assignees
- 19
- Inventors
- 41
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 3 |
| 2017 | 0 | 0 |
| 2018 | 2 | 9 |
| 2019 | 4 | 3 |
| 2020 | 2 | 4 |
| 2021 | 2 | 4 |
| 2022 | 1 | 1 |
| 2023 | 3 | 2 |
| 2024 | 2 | 1 |
| 2025 | 3 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of treating amyotrophic lateral sclerosis (ALS)20 Jan 2026US 12,529,051 B2University of Massachusetts
- Nucleic acid molecules containing spacers and methods of use thereof28 Oct 2025US 12,453,783 B2St. Jude Children?S Research Hospital
- AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells1 Jul 2025US 12,343,408 B2Wayne State University
- Viral gene therapy as treatment for cholesterol storage disease or disorder21 Jan 2025US 12,201,658 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter13 Feb 2024US 11,896,679 B2The Johns Hopkins University
- Mesenchymal progenitor cells for enhancing partial reprogramming of target cells12 Mar 2026US 2026/0069635 A1
- Aav-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells3 Jul 2025US 2025/0213723 A1Wayne State University
- Viral gene therapy as treatment for cholesterol storage disease or disorder22 May 2025US 2025/0161383 A1The United States of America, as represented by the Secretary, Department of Health and Human Servi
- Methods of treating amyotrophic lateral sclerosis (als)23 May 2024US 2024/0167025 A1University of Massachusetts
- Viral vectors for enhanced ultrasound-mediated delivery to the brain16 Feb 2023US 2023/0047753 A1
Most cited
By later US patents
- AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells14US 9,453,241 B2Wayne State University · 2016
- Detargeted adenovirus variants and related methods8US 10,376,549 B2Adcure Biotechnologies, LLC. · 2019
- Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter5US 9,907,863 B2The Johns Hopkins University · 2018
- Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter3US 10,369,234 B2The Johns Hopkins University · 2019
- Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter3US 10,406,245 B2The Johns Hopkins University · 2019